Sagility block deal: Promoter to offload 12% stake at ₹42.45 apiece; deal size ₹2,377 crore
Sagility shares may remain volatile after reports that promoter Sagility B.V. plans to sell a 12% stake for about ₹2,377 crore at ₹42.45 per share, a 5% discount. The promoter held 50.95% at September quarter-end, down from 67.38% a year earlier.
Shares of Sagility are likely to remain volatile in Friday’s session on October 30, as the healthcare services provider’s promoter, Sagility B.V., is reportedly planning to sell a 12% stake in the company through a block deal, according to media reports.The deal is estimated to be worth around ₹2,377 crore, with the promoter expected to sell shares at ₹42.45 apiece, representing a 5% discount to Thursday’s closing price.According to the shareholding data for the September quarter, Sagility B.V. held 2,38,51,29,151 shares, representing a 50.95% stake in the company at the end of the quarter. The promoter has been gradually trimming its stake in the company. In the same period last year, Sagility B.V. held a 67.38% stake.In November last year, Sagility B.V. sold 76.9 crore shares at an average price of ₹47.60 apiece on the NSE.
In a separate transaction on November 21, 2025, BNP Paribas Financial Markets purchased 35 lakh shares at an average price of ₹48.23 apiece on the BSE.Meanwhile, mutual funds held a 15.13% stake in the company, while general retail shareholders owned a 16.1% stake.Sagility shares down 14% in 2026, recover 24% from yearly low The latest stake sale comes at a time when the stock has been reeling under significant selling pressure, falling 14% so far in 2026 to ₹44.65 apiece. Although its performance for the year has remained weak, the stock has recovered 24% from its yearly low of ₹35.83. For the June quarter, the company reported a 46% year-on-year rise in net profit for the first quarter of FY27, driven by strong revenue growth and continued client additions.
The company’s net profit stood at ₹217 crore for the quarter ended June 30, 2026, compared with ₹149 crore in the corresponding period last year. Revenue from operations increased 27.6% year-on-year to ₹1,963 crore, up from ₹1,539 crore a year ago. EBITDA rose 26.6% to ₹438 crore from ₹346 crore, while the EBITDA margin narrowed slightly to 22.3% from 23% in the year-ago quarter. During the quarter, the company said it added 27 new clients, including CareSeed, taking its total client base to 109.Disclaimer: We advise investors to check with certified experts before making any investment decisions.
Related Stories
Around 600% jump in 5 years: Citi maintains 'buy' on Maharatna defence PSU HAL for up to 28% - Check target, rationale
HAL shares have weakened recently, but Citi retained its Buy rating and ₹6,175 target, implying about 28% upside. Citi cited higher inventory and support from engines, helicopters and repairs amid delayed Tejas Mk1A deliveries.
AI relief fails to lift legacy IT stocks as earnings worries weigh
The Indian IT sector has seen a rollercoaster of activity, where mid-sized companies have outperformed their larger peers recently. Increased deal bookings are promising, yet slow revenue growth due to client indecision lingers. The emergence of AI technology brings both new possibilities and pricing pressures for classic services. To sustain their margins in this shifting landscape, companies are honing their operational efficiency.
YES Bank files SC review plea over AT-1 bonds: What does it mean for investors after stock's 15% rebound?
YES Bank has asked the Supreme Court to review its October 15 ruling against the write-down of ₹8,415 crore in AT-1 bonds. The move follows a bondholders’ trustee’s contempt petition seeking restoration of the bonds. The ruling has weighed on the bank’s capital outlook and share price.